Regeneron (NASDAQ: REGN) announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE